Sort
130,381 grants matching “hiv”
Role of B Lymphocytes In HIV Infection And Pathogenesis
$2,241,570Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Chicago Consortium Women's Interagency HIV Study lll
$2,241,084Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2007 · AI
Combination HIV Antiretroviral Rectal Microbicide Program
$2,240,713Ian Michael McGowan · Magee-Women'S Res Inst And Foundation · U19 · FY2009 · AI
WIHS Data Management and Analysis Center (WDMAC)
$2,240,055Stephen John Gange · Johns Hopkins University · U01 · FY2013 · AI
VOLUNTARY COUNSELING, HIV TESTING AND AIDS CARE IN STAND ALONE COMM CENTERS
$2,240,000Ernest O Nyamato · Liverpool Vct · U62 · FY2006 · PS
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder
$2,239,465Tariq M Rana · University Of California, San Diego · U01 · FY2023 · DA
Center for Addiction and Disease Risk Exacerbation
$2,239,343Peter M. Monti · Brown University · P20 · FY2021 · GM
NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$2,238,755Northwestern University · U01 · FY2003 · AI
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,237,757Scott M Hammer · Columbia University Health Sciences · UM1 · FY2016 · AI
The Johns Hopkins University - Uganda Clinical Trials Unit
$2,237,197Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2021 · AI
Molecular Mechanisms of HIV Post-Integration Latency
$2,236,835Eric M Verdin · J. David Gladstone Institutes · P01 · FY2008 · AI
Mindful Body Awareness Training as an Adjunct to Medication Assisted Treatment for Opioid Use Disorder: An ancillary study
$2,235,261Cynthia J Price · University Of Washington · R01 · FY2019 · AT
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$2,234,831Robert A. Gramzinski · Walter Reed Army Institute Of Research · UM1 · FY2019 · AI
Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
$2,234,610Francois Villinger · University Of Louisiana At Lafayette · N01 · FY2025 · AI
Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study
$2,233,828Jennifer R Havens · University Of Kentucky · R01 · FY2021 · DA
Multi-omics Studies of Childhood Complex Traits
$2,233,432Neil Hanchard · National Human Genome Research Institute · ZIA · FY2025 · HG
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder
$2,233,422Tariq M Rana · University Of California, San Diego · U01 · FY2024 · DA
HIV NEUROBEHAVIORAL RESEARCH CENTER
$2,233,212University Of California San Diego · P30 · FY2005 · MH
Center for Addiction and Disease Risk Exacerbation
$2,232,943Peter M. Monti · Brown University · P20 · FY2023 · GM
Molecular Analysis Of Retroviral Genes And Their Products
$2,231,634Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
PROFICIENCY TESTING FOR HIV RAPID TESTS, BIOLOGICAL SAFETY CABINET CERTIFICATION
$2,231,622Fausta Mosha · African Field Epidemiology Network, Ltd · U2G · FY2013 · PS
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
$2,231,473Michael Scott Gordon · Friends Research Institute, Inc. · UG1 · FY2020 · DA
MULTI-COUNTRY LABORATORY QUALITY IMPROVEMENT SUPPORT AND ECHO PROGRAM: DHAPP PARTNERSHIP FOR SUSTAINABLE HIV EPIDEMIC CONTROL
$2,231,250Global Scientific Solutions For Health Llc · · FY2025 · Defense Health Agency
GH11-1150, S. AFRICA: PROVISION OF MEDICAL MALE CIRCUMCISION (MMC) FOR HIV PREVENTION IN KWAZULU NATAL
$2,229,693Miriam Mhazo · Population Services International · U2G · FY2014 · GH
Mechanisms Underlying Clearance of Persistent Infections and Tumors
$2,228,983Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS